We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 138 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 138 → 0 (-138)

100% less funds holding in top 10

Funds holding in top 10: 9 → 0 (-9)

100% less capital invested

Capital invested by funds: $1.91B → $0 (-$1.91B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 138

Holders
–
Holders Change
-138
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
138
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$446M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$180M
3
Millennium Management
Millennium Management
New York
-$116M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$88.5M
5
BFA
BlackRock Fund Advisors
California
-$67.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
DMK
26
David M. Knott
– -$12.9M -128,500 Closed
Northern Trust
27
Northern Trust
Illinois
– -$12.7M -126,778 Closed
SFM
28
Sphera Funds Management
Israel
– -$12.5M -125,074 Closed
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
– -$12.5M -125,000 Closed
ACPU
30
Arrowgrass Capital Partners (US)
Delaware
– -$12.5M -124,752 Closed
COPPSERS
31
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$12.4M -123,762 Closed
DCM
32
DAFNA Capital Management
California
– -$12.1M -120,500 Closed
O
33
OrbiMed
New York
– -$11.9M -118,600 Closed
Geode Capital Management
34
Geode Capital Management
Massachusetts
– -$10.7M -106,924 Closed
PI
35
Putnam Investments
Massachusetts
– -$10M -99,838 Closed
Ameriprise
36
Ameriprise
Minnesota
– -$9.48M -94,547 Closed
Asset Management One
37
Asset Management One
Japan
– -$9.17M -91,394 Closed
GLAM
38
Gardner Lewis Asset Management
Pennsylvania
– -$8.9M -88,800 Closed
Bank of New York Mellon
39
Bank of New York Mellon
New York
– -$8.79M -87,615 Closed
FCMI
40
Foresite Capital Management II
California
– -$7.52M -75,000 Closed
ACA
41
Apis Capital Advisors
New York
– -$5.46M -69,460 Closed
GF
42
Gabelli Funds
New York
– -$6.95M -69,300 Closed
DCM
43
Driehaus Capital Management
Illinois
– -$6.93M -69,085 Closed
Lazard Asset Management
44
Lazard Asset Management
New York
– -$6.43M -64,135 Closed
UOC
45
UBS O'Connor
Illinois
– -$6.27M -62,490 Closed
ECM
46
Endurant Capital Management
California
– -$5.94M -59,250 Closed
BPGAM
47
BTG Pactual Global Asset Management
Bermuda
– -$5.54M -55,300 Closed
TCIM
48
TIAA CREF Investment Management
New York
– -$5.26M -52,449 Closed
OAC
49
OMERS Administration Corp
Ontario, Canada
– -$4.88M -48,700 Closed
State of New Jersey Common Pension Fund D
50
State of New Jersey Common Pension Fund D
New Jersey
– -$4.35M -43,400 Closed
1
2
3 4 5

ASPX Hedge Fund Activity: Q2 2015 in Review

0 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q2 2015, worth a combined $0 — down 100% from $1.91B a quarter earlier.

Sellers outnumbered buyers: 138 funds closed out of ASPX and 0 opened new positions — a net loss of 138 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $446M sold.

  • 0 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q2 2015, down from 138 in Q1 2015.
  • Funds reported $0 of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q2 2015 and 138 closed out, a net change of -138 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q2 2015 was Deerfield Management, an estimated $446M sold.

Based on aggregated 13F filings for Q2 2015.